Roadmaps to Regulation: New Psychoactive Substances

On 26 May 2016, the New Psychoactive Substances Act passed into UK law, rendering it illegal to buy, sell or supply any substance deemed to have psychoactive properties. To mark the day, Amanda Feilding and the Beckley Foundation have released this chapter on NPS from our forthcoming report, “Roadmaps to Regulation: Cannabis, Psychedelics, MDMA and NPS.” The chapter explains the medical and social fallacies of applying a blanket ban to this vast array of chemically dissimilar substances, and strategises how we could legally regulate the unquellable market for NPS.

Screen Shot 2016-05-26 at 13.29.59

NPS in the Press: Amanda has shared her perspective on the myriad harms that this new legislation will bring with it in the Metro, Vice: Motherboard and the Mirror.

Read our latest report in the series, Roadmaps to Regulation: MDMA.


"Who would want N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide when they could legally purchase cannabis?"

Amanda Feilding

Roadmaps to Regulation: NPS Chapter (PDF)

NPS Chapter Executive Summary (PDF)

Roadmaps to Regulation: MDMA